SUSTAINCSX.

Trial name or title	SodiUm SeleniTe Administration IN Cardiac Surgery (SUSTAIN CSX®‐Trial)
Methods	Randomised, placebo‐controlled, double‐blind, multicentre trial; 1400 participants across 20 sites in Germany and Canada
Participants	Age: > 18
Interventions	Perioperative supplementation in high‐risk cardiac surgical patients undergoing complicated open heart surgery; drug 1: sodium selenite; drug 2: placebo
Outcomes	Secondary: e.g. RTW (time frame: 6‐months)
Starting date	January 2015
Contact information	Daren K Heyland, MD (dkh2@queensu.ca)
Notes